Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Effect van een transfluthrin-emitter op malaria-incidentie in West-Kenia
apr 2025 | Parasitaire infecties